Cargando…

Prediction of the clinical chemotherapeutic response of stage III lung adenocarcinoma patients by an in vitro short term test.

Detalles Bibliográficos
Autores principales:	Volm, M., Drings, P., Hahn, E. W., Mattern, J.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1988
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246447/ https://www.ncbi.nlm.nih.gov/pubmed/3358911

Ejemplares similares

Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas.
por: Volm, M., et al.
Publicado: (1998)

Relationship between chemoresistance of lung tumours and cigarette smoking.
por: Volm, M., et al.
Publicado: (1990)

Occurrence of a multidrug-resistant phenotype in human lung xenografts.
por: Mattern, J., et al.
Publicado: (1987)

Overexpression of P-glycoprotein and glutathione S-transferase-pi in resistant non-small cell lung carcinomas of smokers.
por: Volm, M., et al.
Publicado: (1991)

Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma.
por: Mattern, J., et al.
Publicado: (1996)

Protein expression profiles indicative for drug resistance of non-small cell lung cancer
por: Volm, M, et al.
Publicado: (2002)

Development of drug resistance in a human epidermoid lung carcinoma xenograft line.
por: Mattern, J., et al.
Publicado: (1988)

Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas.
por: Volm, M., et al.
Publicado: (1997)

Impact of Cytological Sampling on EGFR Mutation Testing in Stage III-IV Lung Adenocarcinoma
por: Davies, Rhian Siân, et al.
Publicado: (2017)

Growth of human bronchial carcinomas in nude mice.
por: Mattern, J., et al.
Publicado: (1985)

The Human Positive Cofactor 4 is a Promising Chemotherapeutic Target in Lung Adenocarcinoma
por: Sun, Tianyu, et al.
Publicado: (2021)

P-glycoprotein expression in treated and untreated human breast cancer.
por: Schneider, J., et al.
Publicado: (1989)

Association of CDX2 and mucin expression with chemotherapeutic benefits in patients with stage II/III gastric cancer
por: Gao, Xianchun, et al.
Publicado: (2023)

Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma
por: Han, Xiaohong, et al.
Publicado: (2019)

A robust CD8(+) T cell-related classifier for predicting the prognosis and efficacy of immunotherapy in stage III lung adenocarcinoma
por: Feng, Jinteng, et al.
Publicado: (2022)

Effect of Chemotherapeutics and Tocopherols on MCF-7 Breast Adenocarcinoma and KGN Ovarian Carcinoma Cell Lines In Vitro
por: Figueroa, Daniela, et al.
Publicado: (2019)

Short-term outcomes of neoadjuvant sintilimab with chemotherapy in stage III non-small cell lung cancer: a case series
por: Fan, Bo-Shi, et al.
Publicado: (2022)

Radiomic Phenotypes for Improving Early Prediction of Survival in Stage III Non-Small Cell Lung Cancer Adenocarcinoma after Chemoradiation
por: Luna, José Marcio, et al.
Publicado: (2022)

Possible pathways used to predict different stages of lung adenocarcinoma
por: Chen, Xiaodong, et al.
Publicado: (2017)

Immunoscore Predicts Survival in Early-Stage Lung Adenocarcinoma Patients
por: Zhao, Zihuan, et al.
Publicado: (2020)

Prediction of the Growth Rate of Early-Stage Lung Adenocarcinoma by Radiomics
por: Tan, Mingyu, et al.
Publicado: (2021)

Short-term inhalation and in vitro tests as predictors of fiber pathogenicity.
por: Cullen, R T, et al.
Publicado: (1997)

Effect of Chemotherapeutics on In Vitro Immune Checkpoint Expression in Non-Small Cell Lung Cancer
por: Zhao, Yu, et al.
Publicado: (2023)

Prediction of Cancer Drug Resistance and Implications for Personalized Medicine
por: Volm, Manfred, et al.
Publicado: (2015)

A Robust Seven-Gene Signature Associated With Tumor Microenvironment to Predict Survival Outcomes of Patients With Stage III–IV Lung Adenocarcinoma
por: Zhao, Hao, et al.
Publicado: (2021)

Development and validation of a nomogram for predicting overall survival in patients with stage III-N2 lung adenocarcinoma based on the SEER database
por: Zhang, Shengchao, et al.
Publicado: (2023)

Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival
por: Volm, M, et al.
Publicado: (2000)

Is MPP a good prognostic factor in stage III lung adenocarcinoma with EGFR exon 19 mutation?
por: Zhang, Tian, et al.
Publicado: (2017)

Comprehensive molecular characterizations of stage I–III lung adenocarcinoma with tumor spread through air spaces
por: Ye, Ronghao, et al.
Publicado: (2023)

Concerted cell and in vivo screen for pancreatic ductal adenocarcinoma (PDA) chemotherapeutics
por: Layeghi-Ghalehsoukhteh, Somayeh, et al.
Publicado: (2020)

New in vitro system to predict chemotherapeutic efficacy of drug combinations in fresh tumor samples
por: Kischkel, Frank Christian, et al.
Publicado: (2017)

Postoperative Short-term Outcomes Between Sublobar Resection and Lobectomy in Patients with Lung Adenocarcinoma
por: Zhang, Jiaqi, et al.
Publicado: (2020)

Clinical characteristics and prediction model of long-term survival of patients with stage III non-small cell lung cancer
por: Zhang, Jun, et al.
Publicado: (2021)

Short-course or long-course radiation therapy as a part of a neoadjuvant regimen for stage II & III rectal adenocarcinoma?
por: Zhao, Nan, et al.
Publicado: (2019)

In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.
por: Wilson, A. P., et al.
Publicado: (1981)

Pre-treatment platelet counts as a prognostic and predictive factor in stage II and III rectal adenocarcinoma
por: Steele, Morgan, et al.
Publicado: (2017)

Apoptotic and chemotherapeutic properties of iron (III)-salophene in an ovarian cancer animal model
por: Lange, Thilo S, et al.
Publicado: (2009)

Inhibition of metabotropic glutamate receptor III facilitates sensitization to alkylating chemotherapeutics in glioblastoma
por: Maier, Julian P., et al.
Publicado: (2021)

Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor for survival.
por: Wolf, M., et al.
Publicado: (1991)

Development of a Prognostic Nomogram for Patients with Lung Adenocarcinoma in the Stages I, II, and III Based on Immune Scores
por: Xie, Hui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b2ide5pj3ec9akhh5mohdimeva